Injection Drug User Quality of Life scale (IDUQoL): Psychometric assessment of the Spanish version
DOI:
https://doi.org/10.20882/adicciones.270Keywords:
Quality of life, adaptation scales, psychometric properties, validation, reliability, drug userAbstract
Background: The assessment of quality of life has become one of the priority indicators of outcomes in the field of clinical research. Therefore, it is necessary to use instruments adapted to and validated for the context in which they are to be used. Purpose: To assess the psychometric properties of the IDUQoL (Injection Drug User Quality of Life Scale) in its Spanish adaptation. Method: Participants were 100 persons with a diagnosis of opiate addiction who were on a methadone maintenance programme. They responded to the IDUQoL -in its 21-domain version- and two other quality of life instruments (the SF-36 and the EQ-5D). Results: Good reliability data are obtained (Cronbach’s alpha of 0.92 and Intraclass Correlation Coefficient for the test-retest of 0.79). Exploratory and confirmatory factor analyses and semi-partial correlations analysis confirm the unidimensionality of the construct, with explained variance of 43.8% and adequate fit indices (GFI = 0.92; CFI = 0.97; RMSEA = 0.044). Convergent and criterion-related validity were also quite adequate (correlation coefficients with the SF-36 and EQ-5D were situated between 0.34 and 0.61, and with other criterion variables between 0.23 and 0.39; pReferences
Hilton BA, Thompson R, Moore-Dempsey L, Janzen RG. Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature. J Adv Nurs 2001; 33: 357-70.
Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006; 25:611-24.
Ball AL. HIV, injecting drug use and harm reduction: a public health response. Addiction 2007; 102: 684-90.
Iraurgi I. La calidad de vida como indicador de resultados en la clínica de las drogodependencias. E-Boletín. Instituto para el Estudio de las Adicciones, 1999. Disponible en: http://www.ieanet.com/ boletin/ opinion.html?o=25 . [Consultado 14-12-2007].
Fischer B, Rehm J, Kim G. Quality of Life (QoL) in Illicit Drug Addiction Treatment and Research: Concepts, Evidence and Questions. En: Von Bernd-Westermann H, Jellinek C, Bellmann GU. Substitution: Zwischen
Leben und Sterben. Weinheim: Deutscher Studien Verlag; 2001, p. 21-40.
Fernández-Miranda JJ. La calidad de vida en adicciones: Una medida de la efectividad de los tratamientos. Anal Psiq 2003; 19: 377-84.
Bowling A. Measuring Health: A review of quality of life measurement scales. Buckingham; Open University Press; 1991. Edición en castellano: La medida de la salud. Revisión de las escalas de medida de la calidad
de vida. Barcelona: Masson; 1994.
Bowling A. Measuring disease. Buckingham-Philadelphia: Open University Press; 1995.
Bobes J, González MP, Bousoño M, editores. Calidad de vida en las esquizofrenias. Barcelona; JR Prous Editores; 1995.
Badia X, Salamero M, Alonso J, Ollé A. La medida de la salud. Guía de escalas de medición en español. Barcelona: PPU; 1996. / 2ª edición. Barcelona: Edimac; 1999.
Katschnig H, Freeman H, Sartorius N. editores. Calidad de vida en trastornos mentales. Barcelona: Masson; 2000.
Guyatt GH, Veldhuyzen van Zanten SJO, Feeny D, Patrick DL. Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J 1989; 140:1441-8.
Guyatt GH. A taxonomy of health status instruments. J Rheumat 1995; 22: 1188-90.
Badia X, Carné X. La evaluación de la calidad de vida en el contexto del ensayo clínico. Med Clín (Barc) 1998; 110: 550-6.
Iraurgi I. Instrumentos de Evaluación de la Calidad de Vida Relacionada con la Salud en Toxicomanías. En: Iraurgi I, González-Saiz F, editores. Instrumentos de evaluación en drogodependencias. Madrid: Aula
Médica; 2002, p. 481-511.
Morales-Manrique CC, Valderrama-Zurian JC, Castellano-Gómez M, Aleixandre-Benaventa R. Medición de la calidad de vida e importancia de la
atención a las necesidades autopercibidas en pacientes drogodependientes. Trast Adict 2006; 8: 212-21.
Wan C, Fang J, Zhang Y, He C, Chen L. Development of a Quality of Life Scale for Drug Addicts (QOL-DA). Qual Life News Lett, 1997; 17: 6.
Lozano O, Rojas AJ, Pérez-Meléndez C. Construcción de un Test para Medir la Calidad de Vida Relacionada con la Salud Específico para Drogodependientes. Sevilla; Dirección General para las Drogodependencias y Adicciones, Consejería para la Igualdad y Bienestar
Social, Junta de Andalucía; 2006.
Lozano-Rojas OM, Rojas-Tejada A, Pérez-Meléndez C, Apraiz B, Sánchez-Muñoz F, Marín-Bedoya A. Test para la Evaluación de la Calidad de Vida en Adictos a Sustancias Psicoactivas (TECVASP): estudios de
fiabilidad y validez. Trast Adict 2007; 9: 97-107.
Brogly SB, Bruneau J, Palepu A, Mercier C, Franco E. (2002). Validation of an Instrument to Measure the Quality of Life of Drug Users: The Injection Drug User Quality of Life Scale (IDUQOL). 11th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, Manitoba. Abstract in: Cannad J Infec Dis 2002; 13:Supl A.
Brogly SB, Mercier C, Bruneau J, Palepu A, Franco E. Towards more effective public health programming for injection drug users: Development and evaluation of the injection drug user quality of life scale. Subst Use
Misuse 2003; 38: 965-92.
Hubley AM, Russell LB, Palepu A. Injection Drug Use Quality of Life scale (IDUQOL): A validation study. Health Qual Life Outcomes 2005; 3: 43.
Brogly SB, Palepu A, Franco E, Bruneau J. The Injection Drug User Quality of Life Scale (IDUQOL). 1st Canadian Network for Vaccines and Immunotherapeutics (CANVAC). Annual Scientific Meeting, Lake Louise;
Brogly SB, Palepu A, Franco E, Bruneau J. Development of an instrument to measure the quality of life of injection drug users: the Injection Drug User Quality of Life Scale (IDUQOL). 10th Annual Canadian Conference on HIV/AIDS Research, Toronto. Abstract in: Cannad J Infec Dis 2001; 12: Supl B.
Brogly SB, Bruneau J, Palepu A, Franco E. The quality of life of Montreal injection drug users: a pursuit towards more effective public health programming. Int Conf AIDS 2002; 14: 7-12.
Brogly SB, Bruneau J, Palepu A, Franco E. Quality of Life and Public Health Program Use of Montreal Cocaine and Heroin Injection Drug Users. 12th Annual Canadian Conference on HIV/AIDS Research, Halifax, Nova Scotia. Abstract in: Cannad J Infec Dis 2003; 14:Supl A.
Ha tt ie J. Methodology rev iew: As ses s ing unidimensionality of tests and items. Appl Psych Meas 1984; 20: 1-14.
Hattie J. An empirical study of the various indices for determining unidimensionality. Multivar Behav Res 1985; 19: 49-78.
Gorsuch RL. Factor analysis. Hillsdale, NJ: Lawrence Erlbaum; 1983.
Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multidimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Brit J Addict
; 87: 733-42.
González-Saiz F, Salvador-Carulla L, Martínez-Delgado JM, López-Cárdenas A, Ruz-Franzi I. Estudio de validez y fiabilidad de la versión española de la Entrevista Clínica Opiate Treatment Index (OTI). En: Iraurgi I, González-Saiz F, editores. Instrumentos de evaluación en drogodependencias. Madrid: Aula Médica; 2002, p.309-59.
McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index. J Subs Abuse Treat 1992; 9: 199-213.
González-Saiz F, Salvador-Carulla L, Martínez-Delgado JM, López-Cárdenas A, Ruz-Franzi I, Guerra-Díaz D. Estudio de fiabilidad y validez de la versión española de la Entrevista Clínica Addiction Severity Index (ASI). En: Iraurgi I, González-Saiz F. editores. Instrumentos de evaluación en drogodependencias. Madrid: Aula Médica; 2002, p. 271-307.
Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36): Conceptual framework and item selection. Med Care 1992; 30: 473-83.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey. Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultado clínicos. Med Clin (Barc) 1995; 104: 771-6.
Alonso J, Regidor E, Barrio G, Prieto L, Rodríguez C, de-la-Fuente L. Valores poblacionales de referencia de la versión española del Cuestionario de Salud SF-36. Med Clin (Barc) 1998; 111: 410-6.
Gandek B, Ware JE. Translating functional health and well-being: International Quality of Life Assessment (IQOLA) Project studies of the SF-36 Health Survey. J Clin Epidemiol 1998; 51: 891-1214.
IMIN - Institut Municipal d’Investigació Mèdica. Manual de puntuación de la versión española del Cuestionario de Salud SF-36. Disponible en: http://www.imim.es/imim/cas/c-QQV.htm [Consultado 14-04-2007].
EuroQol Group. EuroQol - A new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
Badía X, Roset M, Montserrat S, Herdman M, Segura A. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc) 1999; 112, Supl 1: 79-96.
Prieto L, Sacristán J. What is the value of social values? The uselessness of assessing health-related quality of life through preference measures. BMC Med Res Methodology 2004; 4: 10.
Pett MA, Lackey NR, Sullivan JJ. Making sense of factor analysis: The use of factor analysis for instrument development in health care research. Thousand Oaks, CA: SAGE Publications; 2003.
Bentler PM, Wu EC. EQS for Windows User´s Guide. Encino, CA: Multivariate Software Inc; 1995.
Bentler PM, Bonett DG. Significant test and goodness of fit in the analysis of covariances structures. Psychol Bull 1980; 88: 588-606.
Marsch HW, Balla J, McDonald RP. Goodness of fit in confirmatory factor analysis: the effect of sample size. Psychol Bull 1988; 103: 391-410.
Clark LA, Watson D. Constructing validity: Basic issues in objective scale development. Psychol Assessment 1995; 7: 309-19.
Nunnally JC, Berstein IJ. Teoría psicométrica. 3ª Edición. México: McGraw-Hill; 1995.
Messick S. Validity of test interpretation and use. Research Report No. 90-11. Educational Testing Service; 1990.
Foster SL, Cone JD. Validity issues in clinical assessment. Psychol Assessment 1995; 7: 248-60.
Hair JF, Anderson RE, Tatham RL, Black WC. Análisis Multivariante. 5ª edición. Prentice Hall International, Madrid; 1999.
Morales-Manrique CC, Castellano-Gómez M, Valderrama-Zurian JC, Aleixandre-Benaventa R, Papelu A, and Cocaine Group. Cross cultural adaptation of the Injection Drug User Quality Of Life Scale (IDUQOL) in Spanish drug dependent population, with or without injectable consumption: Quality of Life Scale-Spanish (DUQOLSpanish). Addic Behav 2007; 32: 1913-21.
